NCT05936073Recruiting
DELTA DESCRIBE: the French Collaborative Project
Source: ClinicalTrials.gov · Last updated 28 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Our global objective is to draw up a photograph of HDV patients over one year in metropolitan France and identify the barriers of screening and care. The investigator suspects a mismatch between HBV and HDV screening, the first step for specialized care pathway in metropolitan France.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 734 (estimated)
- First submitted
- 27 Jun 2023
- Start date
- 22 Jan 2024
- Primary completion date
- 22 Jun 2025
- Lead sponsor
- University Hospital, Limoges
- NCT number
- NCT05936073
What you commit to
- Study type: Observational
- Planned participants: 734
- From 22 Jan 2024 to the primary completion date, 22 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Opposition expressed by the patients for the collection of their data
Who the study is looking for
- \>18 years at the second step
- HDV RNA positive patients identified at the second step
- Patients non opposed to the collection of their data
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Limoges Coordinator of this site? Confirm its status | Limoges | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.